myeloid

(redirected from myelogenous)
Also found in: Dictionary, Medical.

myeloid

[′mī·ə‚lȯid]
(anatomy)
Of or pertaining to bone marrow.
Of or pertaining to the spinal cord.
References in periodicals archive ?
[ClickPress, Tue Jun 18 2019] Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
[UKPRwire, Tue Jun 18 2019] Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
The Type II Variation application for BOSULIF for adults with newly diagnosed chronic phase Ph+ CML was based on results from BFORE (Bosutinib trial in First line chrOnic myelogenous leukemia tREatment), a randomized multicenter, multinational, open-label, Phase 3, head-to-head study of BOSULIF 400 mg versus imatinib 400 mg, a current standard of care.
Chronic Myelogenous Leukemia (CML) is a myeloproliferative hematopoietic neoplasm, characterized by a balanced translocation of Abelson gene on chromosome 9q34 with breakpoint cluster region gene on chromosome 22q11.2 (BCR-ABL1) [1].
Downs syndrome is found to be closely linked to Acute Myelogenous Leukaemia.10 Considering Trisomy 21 as one of the chromosomal disorder associated with Leukaemia, further studies should be conducted to define association of various leukaemias with Turner Syndrome.
Eleven-year-old Naomi Oakes was due to attend the star's concert in Phoenix in August but was diagnosed with acute myelogenous leukaemia on June 25, according to E!
Mazzarella age 51, sadly passed away Wed., March 4, 2015 at the UMass Medical Center-University Campus, Worcester, MA, from complications of Acute Myelogenous Leukemia that he fought for 3 years with his family by his side.
David Blumenfeld--Brad's brother--continues to battle chronic myelogenous leukemia (CML) seven years after his diagnosis.
INTRODUCTION: Chronic Myelogenous leukemia (CML) is a disorder of myeloproliferative lineage.
The trial, which will be conducted across multiple sites in the United States, Asia and Europe, will evaluate BOSULIF, administered at a starting dose level of 400 mg daily, as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukaemia, chronic myelogenous leukaemia, multiple myeloma, follicular lymphoma, carcinoid tumour, and malignant melanoma.
Hollie was born with Down's syndrome, and at just 14 months old was diagnosed with acute myelogenous leukaemia.